U.S. Markets open in 2 hrs 51 mins
  • S&P Futures

    3,402.50
    +9.00 (+0.27%)
     
  • Dow Futures

    27,623.00
    +42.00 (+0.15%)
     
  • Nasdaq Futures

    11,534.50
    +42.25 (+0.37%)
     
  • Russell 2000 Futures

    1,602.40
    +0.30 (+0.02%)
     
  • Crude Oil

    39.10
    +0.54 (+1.40%)
     
  • Gold

    1,901.00
    -4.70 (-0.25%)
     
  • Silver

    24.42
    0.00 (0.00%)
     
  • EUR/USD

    1.1816
    +0.0003 (+0.0236%)
     
  • 10-Yr Bond

    0.8010
    0.0000 (0.00%)
     
  • Vix

    32.44
    +4.89 (+17.75%)
     
  • GBP/USD

    1.3019
    -0.0002 (-0.0130%)
     
  • USD/JPY

    104.6410
    -0.1940 (-0.1851%)
     
  • BTC-USD

    13,237.44
    +127.90 (+0.98%)
     
  • CMC Crypto 200

    263.36
    -0.05 (-0.02%)
     
  • FTSE 100

    5,791.31
    -0.70 (-0.01%)
     
  • Nikkei 225

    23,485.80
    -8.54 (-0.04%)
     

TriRx Pharmaceutical Services acquires MSD Animal Health manufacturing site located in Segré-en Anjou Bleu, France including long-term supply agreement

·2 mins read

NORWALK, Conn., Sept. 1, 2020 /PRNewswire/ -- TriRx Pharmaceutical Services, a global contract development and manufacturing organization (CDMO) serving the biopharmaceutical market, today announced that it has finalized an agreement with MSD Sante Animale, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), to acquire the operations and ownership of their manufacturing site located in Segré, France.

TriRx Pharmaceutical Services - Segré-en Anjou Bleu, France
TriRx Pharmaceutical Services - Segré-en Anjou Bleu, France

Timothy C. Tyson, Chairman & CEO of TriRx stated, "We are excited to welcome the Segre team to the TriRx family and to partner with MSD Animal Health to continue to provide important products to the market. This transaction allows us to continue our expansion as a global CDMO while assuring continuity of supply of animal health products from the Segré site. The site's history of exceptional performance and the world class knowledge and experience of the site staff expand TriRx service offerings into sterile suspensions and liquids and non-sterile ointments and liquids." The site currently manufactures a range of veterinary products and has over ninety employees.

The state-of-the-art integrated facility has dedicated office, production, sampling and warehouse areas and delivers products to all major global markets. The agreement has officially been executed today with all customary regulatory, regional and local approvals. "This site will transition to a worldwide center of contract manufacturing excellence in the fast growing, animal health market", said Tyson. "And will continue to be a significant contributor to the local economy", Tyson added.

About TriRx

TriRx Pharmaceutical Services is a global contract development and manufacturing organization (CDMO) serving the biopharmaceutical market. Headquartered approximately 50 miles outside of New York City in Norwalk, Connecticut, TriRx operates facilities providing state-of-the-art laboratory, manufacturing, packaging and warehousing capabilities. Visit www.trirx.com.

For further information:

Name Jeremy R Tatum, VP Sales
Email jrtatum@trirx.com
Tel 256-714-1839

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/trirx-pharmaceutical-services-acquires-msd-animal-health-manufacturing-site-located-in-segre-en-anjou-bleu-france-including-long-term-supply-agreement-301120783.html

SOURCE TriRx Pharmaceutical Services